CanPharma starts exclusive distribution of CBDinol

February 19, 2020
cbdinol-bodegon-1200x968.jpg

CanPharma extends its high-quality product range with the certified full spectrum extract, CBDinol. CBDinol with a CBD concentration of 6% (PZN 16353901) or 15% (PZN 16353870) is now exclusively available for pharmacies from CanPharma.

CBDinol is made from EU certified hemp and has no psychoactive effect due to its THC content of less than 0.2%. It is well tolerated and easy to use. CBDinol consists of extracted hemp seed oil and contains the entire spectrum of cannabinoids, terpenes and nutrients. This is guaranteed by a gentle manufacturing process and responsible cultivation of the hemp plants.

CBDinol is obtained from a special extraction process using ethanol, with no addition of any additives. All product batches are laboratory tested to ensure the highest possible quality and stability of the product. The hemp plants are free from GMOs and chemical fertilisers, and are also free from gluten, preservatives and dyes. The production runs accordingly to strict European standards.

www.cbdinol.com

Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.

MEMBER OF

OFFICES

CanPharma GmbH
Wiesbadener Str. 29,
16515 Oranienburg, Germany

 

REPRESENTATIVE OFFICES

Berlin
Rosenthaler Str. 34
10178 Berlin
Germany

Barcelona
Gran de Gràcia 15, 1-1
08012 Barcelona
Spain